Tanner Pharma Group to Present at Bourne Partners 5th Annual Global Healthcare Executive Summit

Joshua Cooper to Moderate Healthcare Services Panel, “Changing Dynamics of Pharma Services”


CHARLOTTE, N.C., August 21, 2015 – Tanner Pharma Group will be largely showcased at the upcoming Bourne Partners Fifth Annual Global Healthcare Executive Summit on September 3, in Charlotte, North Carolina.

The conference, held at the internationally renowned Mint Museum, will feature top executives participating in a variety of panel discussions regarding healthcare and pharmaceutical issues and trends, as well as opportunities for attendees to interact one-on-one with industry leaders and innovators.

Conference attendees will include global healthcare and consumer executives from a variety of disciplines, including the pharmaceutical, hospital and healthcare technology sectors; private equity investors; and partners, investors, and clients of Bourne Partners and Tanner Pharma Group.

Joshua Cooper, Director of Corporate Development, will lead the Healthcare Services Panel, “Changing Dynamics of Pharma Services.”  Below is a representative list of panellists participating in the discussion:

David W. Bryant, Chairman and CEO of SeLux Diagnostics, Inc.

David Crane, Chairman and CEO of National Surgical Healthcare

Derek Hennecke, CEO and President of Xcelience

Michael Kane, CEO and Founder of Agilem Strategy, LLC.

“The panel is a great opportunity to showcase thought leaders in the healthcare services space and discuss opportunities in this rapidly evolving sector” said Mr. Cooper.

Tanner Pharma Group will also present a corporate overview highlighting recent hyper-growth and global expansion.

The two-day event is hosted by Bourne Partners, a leading healthcare and consumer-healthcare investment banking, merchant banking, and investment firm.

The fifth annual Bourne Partners Global Healthcare Executive Summit, featuring guest speaker, Jeff Gordon, a four-time NASCAR Series champion and presenters from leading pharmaceutical, pharma services, specialty pharma, biotech companies and investors, will take place Sept. 2-3 in Charlotte, N.C.

For additional information about Bourne Partners or the Bourne Partners Global Healthcare Executive Summit, please contact your Bourne Partners representative or Kristi Orange at 704-714-8367 or korange@bourne-partners.com.

About Tanner Pharma Group

For over 15 years, Tanner’s executive team has provided specialty distribution of pharmaceuticals from markets of availability to markets of need. When healthcare providers in international markets require treatments not currently available in their home market, they rely on Tanner to source and deliver the product from its global network of pharmaceutical manufacturers. Based on its track record of accountability and experience managing regulatory-compliant access programs, top pharmaceutical and biotech companies partner with Tanner to develop and manage their global access programs. By partnering with Tanner, pharma and biotech companies are able to focus on their primary markets while ensuring that patients in international markets of need are receiving their products through a strictly controlled channel.

Tanner’s International Access Division serves providers in 24 of the most challenging countries by developing, implementing and managing global access programs including Named Patient Programs, Expanded Access Programs, Compassionate Use Programs, Government & Private Provider Tender fulfillment and Emergency Supply allocations. Tanner’s Clinical Trials Division procures comparator products for manufacturers, CRO’s and research centers from a broad range of sources. Additionally, the company is able to provide clinical trial logistics and inventory management for trials conducted in the U.S., Europe, Mexico and Brazil.

Headquartered in the U.S., Tanner’s reach includes Europe, Northeast Asia, Southeast Asia, the Middle East, Australia, Canada and Latin America, including Brazil, Mexico, the Caribbean, Central America and all of South America.

For more information about Tanner Pharma Group, please visit www.tannerpharma.com.

For more information about Merz or the Company’s products, please visit www.merzusa.com.

Contact Us